SI-BONE, Inc. SIBN
Set alert
At close
Pre-market · Nov 3, 4:00 AM ET
- YTD
- +2.54%
- 1 year
- +36.35%
- Open
- 21.57
- Prev close
- 21.23
- Mkt cap
- 906.23M
- Vol
- 1.37M
- Avg vol
- 579.50K
- EPS
- -0.34
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 20.19
- High
- 21.83
- Forward P/E
- -67.74
- Beta
- 0.66
- Short ratio
- 8.24
- Inst. own
- 109.52%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 5, 2024
- 50-d avg
- 19.33
- 200-d avg
- 16.36
- 1y target
- 25.44
5D chart
Signals (108)
| Name | Time | Ago |
|---|---|---|
| SMA: Bullish | Oct 30, 3:55 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:35 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:35 PM | 3 days ago |
| SMA: Bullish | Oct 30, 3:10 PM | 3 days ago |
| SMA: Bearish | Oct 30, 3:05 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:55 PM | 3 days ago |
| RSI: Oversold | Oct 30, 2:20 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 1:25 PM | 3 days ago |
| SMA: Bullish | Oct 30, 1:15 PM | 3 days ago |
| RSI: Oversold | Oct 30, 12:40 PM | 3 days ago |
| RSI: Oversold | Oct 30, 12:25 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:10 PM | 3 days ago |
| MACD: Sell Signal | Oct 30, 12:10 PM | 3 days ago |
| RSI: Oversold | Oct 30, 12:10 PM | 3 days ago |
| SMA: Bearish | Oct 30, 11:50 AM | 3 days ago |
| SMA: Bullish | Oct 30, 11:30 AM | 3 days ago |
| MACD: Buy Signal | Oct 30, 10:35 AM | 3 days ago |
| RSI: Oversold | Oct 30, 9:50 AM | 3 days ago |
| RSI: Oversold | Oct 30, 9:30 AM | 3 days ago |
| SMA: Bearish | Oct 29, 3:15 PM | 4 days ago |
Newest 20 of 108.
News
8 hours ago seekingalpha.com
SI-BONE, Inc. (SIBN) Q3 2026 Earnings Call Transcript
SI-BONE, Inc. (SIBN) Q3 2026 Earnings Call Transcript
10 hours ago marketbeat.com
SiBone Q3 Earnings Call Highlights
SiBone NASDAQ: SIBN reported third-quarter 2026 revenue growth of 14.5% as procedure demand accelerated, active physician adoption expanded and profitability improved. The company said it is building…
11 hours ago zacks.com
Si-Bone (SIBN) Reports Q3 Loss, Tops Revenue Estimates
Si-Bone (SIBN) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.11 per share a year ago.
12 hours ago benzinga.com
SI-BONE Q3 2026 Earnings Call Transcript
SI-BONE (NASDAQ:SIBN) reported third-quarter financial results on Monday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
-
14 hours ago benzinga.com
SI-BONE Affirms FY2026 Sales Guidance of $231.000M-$233.000M vs $232.024M Est
SI-BONE (NASDAQ:SIBN) affirms FY2026 sales outlook from $231.000 million-$233.000 million to $231.000 million-$233.000 million vs $232.024 million estimate.
-
14 hours ago benzinga.com
SI-BONE Q3 EPS $(0.08) Beats $(0.13) Estimate, Sales $55.704M Beat $55.404M Estimate
SI-BONE (NASDAQ:SIBN) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.13) by 33.33 percent. This is a 27.27 percent increase over losses of $(0.11) per…
14 hours ago globenewswire.com
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2026 and Reaffirms 2026 Revenue Guidance
Delivered ~20 % U.S. procedure volume growth in the third quarter Third Quarter 2026 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $55.7 million,…
4 days ago globenewswire.com
SI-BONE To Present at UBS Global Healthcare Conference on November 10, 2026
SAN JOSE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone,…
-
2 weeks ago benzinga.com
Truist Securities Maintains Buy on SI-BONE, Raises Price Target to $25
Truist Securities analyst Richard Newitter maintains SI-BONE (NASDAQ:SIBN) with a Buy and raises the price target from $23 to $25.